COMBINATION THERAPIES COMPRISING APREMILAST AND TYK2 INHIBITORS
Provided herein are methods of treating diseases and disorder responsive to the inhibition of PDE4 comprising administering apremilast and a Tyk2 inhibitor to a subject. Also provided herein are pharmaceutical compositions comprising apremilast and a Tyk2 inhibitor.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are methods of treating diseases and disorder responsive to the inhibition of PDE4 comprising administering apremilast and a Tyk2 inhibitor to a subject. Also provided herein are pharmaceutical compositions comprising apremilast and a Tyk2 inhibitor. |
---|---|
Bibliography: | Application Number: US202217739506 |